3 articles
TLDR Moderna stock plunged more than 17% to $202.63 after early publication of its melanoma vaccine trial results. The Merck-Moderna treatment reduced melanoma recurrence or death risk by 42% and…
Moderna (NASDAQ: MRNA ) stock experienced a brutal 24 hours of trading, dropping 17.57% from $245.81 to $202.63 on October 22, and extending the losses by another 4.40%, falling to…
President Donald Trump – or his investing team – made thousands of stock trades throughout 2026, many of which recorded returns that were as rapid as they were impressive .…
